Literature DB >> 7613897

Aggressive fibromatosis (non-familial desmoid tumour): therapeutic problems and the role of adjuvant radiotherapy.

J T Plukker1, I van Oort, A Vermey, I Molenaar, H J Hoekstra, A K Panders, W V Dolsma, H S Koops.   

Abstract

Aggressive fibromatosis is a rare soft tissue tumour with a high tendency to local recurrence, even after apparently adequate resection. Wide local excision with a margin of at least 3 cm, depending on the anatomical location, should be performed to improve rates of recurrent disease. There is no consensus concerning the role of radiotherapy in the treatment of these lesions. The clinical findings of 39 cases diagnosed between 1972 and 1991 were reviewed retrospectively. Local control was effected in 19 of 32 patients treated with surgery alone after a median (range) follow-up of 72 (18-236) months. There were 40 cases of recurrent fibromatosis in 15 patients. Local control was obtained in 13 of 14 patients who received radiotherapy using a wide-field technique and doses of more than 50 Gy over a period of 5 weeks after marginal or incomplete resection of primary or recurrent lesions (P < 0.001). The results suggest that in a selected group of patients with aggressive fibromatosis radiotherapy may effectively achieve control of residual disease after surgery without marked disfigurement and loss of function.

Entities:  

Mesh:

Year:  1995        PMID: 7613897     DOI: 10.1002/bjs.1800820424

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  24 in total

1.  [A rare case of intestinal perforation].

Authors:  C Geis; C Weitzel; C Güsgen; J Tuttlies; S Vulpius; R Schwab
Journal:  Chirurg       Date:  2017-11       Impact factor: 0.955

2.  Development and rapid growth of a desmoid tumor in the surgical corridor after suboccipital craniotomy for recurrent low-grade astrocytoma.

Authors:  Todd McCall; Ganesh Rao; Randy Jensen
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

3.  [Desmoid-type fibromatosis (aggressive fibromatosis)].

Authors:  C Kuhnen; M Helwing; S Rabstein; H-H Homann; K-M Müller
Journal:  Pathologe       Date:  2005-03       Impact factor: 1.011

4.  A 66-year-old male with lower abdominal lump: an unusual presentation of an uncommon abdominal pathology.

Authors:  Mohamed Saleem Noormohamed; Christodoulos Neophytou; Yogesh Jain; Saumitra Rawat
Journal:  BMJ Case Rep       Date:  2012-03-27

5.  Prognostic factors for desmoid tumor: a surgical series of 233 patients at a single institution.

Authors:  Wei-Gen Zeng; Zhi-Xiang Zhou; Jian-Wei Liang; Hui-Rong Hou; Zheng Wang; Hai-Tao Zhou; Xing-Mao Zhang; Jun-Jie Hu
Journal:  Tumour Biol       Date:  2014-05-02

Review 6.  Aggressive fibromatosis of the head and neck: a new classification based on a literature review over 40 years (1968-2008).

Authors:  Astrid L Kruse; Heinz T Luebbers; Klaus W Grätz; Joachim A Obwegeser
Journal:  Oral Maxillofac Surg       Date:  2010-12

7.  A prognostic nomogram for prediction of recurrence in desmoid fibromatosis.

Authors:  Aimeé M Crago; Brian Denton; Sébastien Salas; Armelle Dufresne; James J Mezhir; Meera Hameed; Mithat Gonen; Samuel Singer; Murray F Brennan
Journal:  Ann Surg       Date:  2013-08       Impact factor: 12.969

8.  A giant mesenteric fibromatosis case presenting with mechanical intestinal obstruction and successfully resected with partial duodeno-jejunectomy and right hemicolectomy.

Authors:  Coskun Polat; Fatma Aktepe; Serkan Turel; Burc Yazicioglu; Taner Ozkececi; Yuksel Arikan
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

Review 9.  A systematic review of active treatment options in patients with desmoid tumours.

Authors:  X Yao; T Corbett; A A Gupta; R A Kandel; S Verma; J Werier; M Ghert
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

10.  Treatment and follow-up strategies in desmoid tumours: a practice guideline.

Authors:  M Ghert; X Yao; T Corbett; A A Gupta; R A Kandel; S Verma; J Werier
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.